Type 2 Diabetes Breakthrough: New Drug Semaglutide Stops Diabetes On Its Tracks, Relief From Insulin Therapy

Semaglutide stops the progression of diabetes

Researchers have created a new drug, semaglutide, that stops diabetes from getting worse and helps diabetic patients lose weight. Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that can be taken as a pill or injected. It helps to control blood glucose levels by stimulating insulin production and suppressing the release of glucagon which raises blood glucose.

The weight-loss effect of semaglutide is important because a vital aspect of the control of the progression of diabetes is getting patients to shed weight. The new drug could be available to patients within three years, according to experts

Results from the phase II trial of semaglutide carried out by a team of experts at Leicester Diabetes Center in the U.K. and published in the science research journal JAMA, shows that the drug stopped the progression of diabetes in up to 90 percent of patients. The results also showed that it helped about 71 percent of patients to lose weight from the waistline.

Click here to continue and read more…

The Inquisitr